Page last updated: 2024-11-08

triiodothyronine and Squamous Cell Carcinoma of Head and Neck

triiodothyronine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Haas, M1
Lein, A1
Fuereder, T1
Schnoell, J1
Brkic, FF1
Campion, NJ1
Liu, DT1
Kadletz-Wanke, L1
Heiduschka, G1
Jank, BJ1

Other Studies

1 other study available for triiodothyronine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumab.
    International immunopharmacology, 2023, Volume: 123

    Topics: Antibodies, Monoclonal, Humanized; Carcinoma; Head and Neck Neoplasms; Humans; Hyperthyroidism; Prog

2023